74 related articles for article (PubMed ID: 8760334)
21. Transcriptional responses to ionizing radiation reveal that p53R2 protects against radiation-induced mutagenesis in human lymphoblastoid cells.
Tsai MH; Chen X; Chandramouli GV; Chen Y; Yan H; Zhao S; Keng P; Liber HL; Coleman CN; Mitchell JB; Chuang EY
Oncogene; 2006 Jan; 25(4):622-32. PubMed ID: 16247478
[TBL] [Abstract][Full Text] [Related]
22. Identification and characterization of genes whose expressions are altered in rat 6 fibroblasts transformed by mutant p53(val135).
Yam JW; Zheng JY; Hsiao WL
Biochem Biophys Res Commun; 1999 Dec; 266(2):472-80. PubMed ID: 10600527
[TBL] [Abstract][Full Text] [Related]
23. P53 regulation and function in normal cells and tumors.
Liu Y; Kulesz-Martin M
Medicina (B Aires); 2000; 60 Suppl 2():9-11. PubMed ID: 11188940
[TBL] [Abstract][Full Text] [Related]
24. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
[TBL] [Abstract][Full Text] [Related]
25. The growth-inhibitory function of p53 is separable from transactivation, apoptosis and suppression of transformation by E1a and Ras.
Hansen RS; Braithwaite AW
Oncogene; 1996 Sep; 13(5):995-1007. PubMed ID: 8806689
[TBL] [Abstract][Full Text] [Related]
26. The role of translation in neoplastic transformation from a pathologist's point of view.
Rosenwald IB
Oncogene; 2004 Apr; 23(18):3230-47. PubMed ID: 15094773
[TBL] [Abstract][Full Text] [Related]
27. p53R2-dependent pathway for DNA synthesis in a p53-regulated cell cycle checkpoint.
Yamaguchi T; Matsuda K; Sagiya Y; Iwadate M; Fujino MA; Nakamura Y; Arakawa H
Cancer Res; 2001 Nov; 61(22):8256-62. PubMed ID: 11719458
[TBL] [Abstract][Full Text] [Related]
28. The SV40 large T antigen-p53 complexes bind and activate the insulin-like growth factor-I promoter stimulating cell growth.
Bocchetta M; Eliasz S; De Marco MA; Rudzinski J; Zhang L; Carbone M
Cancer Res; 2008 Feb; 68(4):1022-9. PubMed ID: 18281476
[TBL] [Abstract][Full Text] [Related]
29. [A protein, molecule of the year 1993].
Bonard EC
Rev Med Suisse Romande; 1994 Feb; 114(2):193-4. PubMed ID: 8140378
[No Abstract] [Full Text] [Related]
30. [Suntanning and p53].
Magnaldo T
Med Sci (Paris); 2007; 23(6-7):581-3. PubMed ID: 17631828
[No Abstract] [Full Text] [Related]
31. Chemical induced alterations in p53 signaling.
Högberg J; Silins I; Stenius U
EXS; 2009; 99():181-208. PubMed ID: 19157062
[TBL] [Abstract][Full Text] [Related]
32. The complexity of p53 modulation: emerging patterns from divergent signals.
Giaccia AJ; Kastan MB
Genes Dev; 1998 Oct; 12(19):2973-83. PubMed ID: 9765199
[No Abstract] [Full Text] [Related]
33. Species-specific regulation of alternative splicing in the C-terminal region of the p53 tumor suppressor gene.
Laverdière M; Beaudoin J; Lavigueur A
Nucleic Acids Res; 2000 Mar; 28(6):1489-97. PubMed ID: 10684946
[TBL] [Abstract][Full Text] [Related]
34. An ATP/ADP-dependent molecular switch regulates the stability of p53-DNA complexes.
Okorokov AL; Milner J
Mol Cell Biol; 1999 Nov; 19(11):7501-10. PubMed ID: 10523638
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints.
Cliby WA; Roberts CJ; Cimprich KA; Stringer CM; Lamb JR; Schreiber SL; Friend SH
EMBO J; 1998 Jan; 17(1):159-69. PubMed ID: 9427750
[TBL] [Abstract][Full Text] [Related]
36. Cell-cycle regulation of mammalian DNA double-strand-break repair.
Hendrickson EA
Am J Hum Genet; 1997 Oct; 61(4):795-800. PubMed ID: 9382087
[No Abstract] [Full Text] [Related]
37. Induced N- and C-terminal cleavage of p53: a core fragment of p53, generated by interaction with damaged DNA, promotes cleavage of the N-terminus of full-length p53, whereas ssDNA induces C-terminal cleavage of p53.
Okorokov AL; Ponchel F; Milner J
EMBO J; 1997 Oct; 16(19):6008-17. PubMed ID: 9312058
[TBL] [Abstract][Full Text] [Related]
38. Signalling to p53: where does it all start?
Kastan MB
Bioessays; 1996 Aug; 18(8):617-9. PubMed ID: 8760334
[TBL] [Abstract][Full Text] [Related]
39. Death squads enlisted by the tumour suppressor p53.
Michalak E; Villunger A; Erlacher M; Strasser A
Biochem Biophys Res Commun; 2005 Jun; 331(3):786-98. PubMed ID: 15865934
[TBL] [Abstract][Full Text] [Related]
40. [Tumor suppressor gene p53: mechanisms of action in cell proliferation and death].
Mendoza-Rodríguez CA; Cerbón MA
Rev Invest Clin; 2001; 53(3):266-73. PubMed ID: 11496714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
